Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

ADDITIONAL INFORMATION TO PROFIT OR LOSS ITEMS (Narrative) (Details)

v3.25.1
ADDITIONAL INFORMATION TO PROFIT OR LOSS ITEMS (Narrative) (Details)
₪ in Thousands, $ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Jan. 10, 2024
Mar. 08, 2023
Apr. 06, 2022
CAD ($)
Dec. 01, 2021
CAD ($)
Dec. 01, 2021
ILS (₪)
Apr. 15, 2024
CAD ($)
Mar. 31, 2023
CAD ($)
Mar. 31, 2023
ILS (₪)
Dec. 31, 2024
CAD ($)
shares
Dec. 31, 2023
CAD ($)
shares
Dec. 31, 2022
CAD ($)
shares
Mar. 31, 2023
ILS (₪)
Dec. 31, 2021
CAD ($)
Dec. 31, 2021
ILS (₪)
Dec. 01, 2021
ILS (₪)
Additional Information To Profit Or Loss Items [Line Items]                              
Net loss                 $ (11,771) $ (10,228) [1] $ (191,301) [1]        
Number of shares issued | shares                 3,085,452 2,232,359          
Put option liability                 $ 0 $ 2,697          
Oranim Plus Pharm LTD. [Member]                              
Additional Information To Profit Or Loss Items [Line Items]                              
Total purchase price       $ 4,900   $ 2,172       $ 2,097         ₪ 11,900
Percentage of acquisition 51.00%     51.00% 51.00% 51.00%                  
Percentage of discount on Put option exercise price in last 12 months                   2.50%          
Percentage of discount on Put option exercise price in next 12 months                   10.00%          
Percentage of extra agreed value on Call option exercise price in first 12 months                   15.00%          
Percentage of discount on Put option exercise price in first 12 months                   15.00%          
Value of common shares issued in business combination             $ 700         ₪ 1,500 $ 2,100 ₪ 5,200  
Cash consideration of business combination       $ 2,100 ₪ 5,200   $ 2,100 ₪ 5,200              
Number of shares issued | shares                     4,184        
Put option liability           $ 1,973       $ 2,697          
Borrowings, interest rate 15.00%                            
Deconsolidation expenses           2,734                  
Panaxia Logistics Ltd. [Member]                              
Additional Information To Profit Or Loss Items [Line Items]                              
Goodwill Impairment           $ 495                  
Sde Avraham Cultivation Facility [Member]                              
Additional Information To Profit Or Loss Items [Line Items]                              
Expense of restructuring activities     $ 4,383             $ 617          
Workforce Reduction Description   The Company reduced its workforce in Israel across all functions (including executives)                          
[1] Loss per share includes the effect of Reverse Share Split (see also Note 18A below).